Photodynamic diagnosis and therapy in gynecology

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 4, 2008, Pages 307-320

  Soergel, Philipp ^a   Löning, Martin ^a   Staboulidou, Ismini ^a   Schippert, Cordula ^a   Hillemanns, Peter ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cervical intraepithelial neoplasia; Gynecology; Photodynamic diagnosis; Photodynamic therapy; Vulvar intraepithelial neoplasia

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; CARBOPLATIN; FLUOROURACIL; IMIQUIMOD; PACLITAXEL; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN; PROTOPORPHYRIN; TEMOPORFIN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONDYLOMA ACUMINATUM; DYSMENORRHEA; ELECTROCOAGULATION; ENDOMETRIOSIS; ENDOMETRIUM ABLATION; HUMAN; HYSTERECTOMY; MASTECTOMY; MENORRHAGIA; NONHUMAN; OVARY CANCER; PAIN; PHOTODYNAMIC THERAPY; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERUS BLEEDING; VULVA TUMOR; VULVAR INTRAEPITHELIAL NEOPLASIA; VULVECTOMY; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 54549103432     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i4.80     Document Type: Review

References (90)

1. Henderson B, Dougherty T. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-57.
2. Walboomers J, Jacobs M, Manos M, Bosch F, Kummer J, Shah K, Snijders P, Peto J, Meijer C, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
3. Lipson R, Pratt J, Baldes E, Dockerty M. Hematoporphyrine derivative for detection of cervical cancer. Obstet Gynecol. 1964;24:78-84.
4. Pahernik SA, Botzlar A, Hillemanns P, Dellian M, Kirschstein M, Abels C, Korell M, Mueller-Hoecker J, Untch M, Goetz AE. Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia. Int J Cancer. 1998;78:310-4.
5. Andikyan V, Kronschnabl M, Hillemanns M, Wang X, Stepp H, Hillemanns P. Fluoreszenzdiagnostik mit 5-ALA-Thermogel bei zervikaler intraepithelialer Neoplasie. Gynäkologisch-geburtshilfliche Rundschau. 2004;44:31-7.
6. Hillemanns P, Weingandt H, Baumgartner R, Diebold J, Xiang W, Stepp H. Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic- induced porphyrin fluorescence. Cancer. 2000;88:2275-82.
7. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489-98.
8. Bigrigg MA, Codling BW, Pearson P, Read MD, Swingler GR. Pregnancy after cervical loop diathermy. Lancet. 1991;337:119.
9. Mathevet P, Chemali E, Roy M, Dargent D. Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP. Eur J Obstet Gynecol Reprod Biol. 2003;106:214-8.
10. Hildesheim A, Herrero R, Wacholder S, Rodriguez A, Solomon D, Bratti M, Schiller J, Gonzalez P, Dubin G, Porras C, Jimenez S, Lowy D, Group. CRHVT. Effect of human papillomavirus 16/18 L1 virus-like particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743-53.
11. Ichimura H, Yamaguchi S, Kojima A, Tanaka T, Niiya K, Takemori M, Hasegawa K, Nishimura R. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Onc. 2003;8:322-5.
12. Muroya T, Suehiro Y, Umayahara K, Akiya T, Iwabuchi H, Sakunaga H, Sakamoto M, Sugishita T, Tenjin Y. Photodynamic therapy (PDT) for early cervical cancer. Gan To Kagaku Ryoho. 1996;23:47-56.
13. Hillemanns P, Korell M, Schmitt-Sody M, Baumgartner R, Beyer W, Kimmig R, Untch M, Hepp H. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int. J. Cancer. 1999;81:34-8.
14. Keefe KA, Tadir Y, Tromberg B, Berns M, Osann K, Hashad R, Monk BJ. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid. Lasers Surg Med. 2002;31:289-93.
15. Barnett AA, Haller JC, Cairnduff F, Lane G, Brown SB, Roberts DJ. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia. Int J Cancer. 2003;103:829-32.
16. Wierrani F, Kubin A, Jindra R, Henry M, Gharehbaghi K, Grin W, Soltz-Szotz J, Alth G, Grunberger W. 5-Aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix-A new experimental approach [In Process Citation]. Cancer Detect Prev. 1999;23:351-5.
17. Bodner K, Bodner-Adler B, Wierrani F, Kubin A, Szolts-Szolts J, Spangler B, Grunberger W. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res. 2003;23:1785-8.
18. Hillemanns P, Wang X, Hertel H, Andikyan V, Hillemanns M, Stepp H, Soergel P. Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2008;198:300.e301-7. Epub 2008 Feb 2021.
19. Andrejevic-Blant S, Major A, Lüdicke F, Ballini J, Wagnières G, Bergh Hvd, Pelte M. Time-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: a fluorescence microscopy study. Lasers Surg Med. 2004;35:276-83.
20. Ridley CM, Frankman O, Jones ISC, Pincus SH, Wilkinson EJ. (Letter to the editor) New nomenclature for vulvar disease: international society for the study of vulvar disease. Lancet. 1989;20:495-6.
21. Cardosi RJ, Bomalaski JJ, Hoffman MS. Diagnosis and management of vulvar and vaginal intraepithelial neoplasia. Obstet Gynecol Clin North Am. 2001;28:685-702.
22. Akoel KM, Welfel J, Gottwald L, Suzin J. Photodynamic diagnosis of vulvar precancerous conditions and invasive cancers using 5-aminolevulinic acid. Ginekol Pol. 2003;74:662-5.
23. Nowakowski Z, Stelmachow J, Spiewankiewicz B, Gerulewicz G. Diagnostic value of the PDD method in evaluation of vulvar lesions. Eur J Gynaecol Oncol. 2005;26:75-8.
24. Rodolakis A, Diakomanolis E, Vlachos G, Iconomou T, Protopappas A, Stefanidis C, Elsheikh H, Michalas S. Vulvar intraepithelial neoplasia (VIN) - diagnostic and therapeutic challenges. Eur J Gynaecol Oncol. 2003;24:317-22.
25. Jayne CJ, Kaufman RH. Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod. J Reprod Med. 2002;47:395-8.
26. Martin-Hirsch PL, Whitehurst C, Buckley CH, Moore JV, Kitchener HC. Photodynamic treatment for lower genital tract intraepithelial neoplasia. Lancet. 1998;351:1403.
27. Hillemanns P, Untch M, Dannecker C, Baumgartner R, Stepp H, Diebold J, Weingandt H, Pröve F, Korell M. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int. J. Cancer. 2000;85:649-53.
28. Fehr MK, Hornung R, Schwarz VA, Simeon R, Haller U, Wyss P. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gyn. Oncol. 2001;80:62-6.
29. Fehr M, Hornung R, Degen A, Schwarz V, Fink D, Haller U, Wyss P. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30:273-9.
30. Campbell S, Gould D, Salter L, Clifford T, Curnow A. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Br J Dermatol. 2004;151:1076-80.
31. Chen K, Chang B, Ju M, Zhang X, Gu H. Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol. 2007;156:516-20.
32. Wang X, Wang H, Wang H, Xu S, Liao K, Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata. Br J Dermatol. 2004;151:880-5.
33. Stefanaki I, Georgiou S, Themelis G, Vazgiouraki E, Tosca A. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. Br J Dermatol. 2003;149:972-6.
34. Ross E, Romero R, Kollias N, Crum C, Anderson R. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol. 1997;137:736-42.
35. Boente MP, Chi DS, Hoskins WJ. The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. Semin Oncol. 1998;25:326-34.
36. Muderspach L, Muggia FM, Conti PS. Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues. Cancer Treat Rev. 1996;21:499-511.
37. Nicoletto MO, Tumolo S, Talamini R, Salvagno L, Franceschi S, Visona E, Marin G, Angelini F, Brigato G, Scarabelli C, Carbone A, Cecchetto A, Prosperi A, Rosabian A, Giusto M, Cima GP, Morassut S, Nascimben O, Vinante O, Fiorentino MV. Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission - a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study. J Clin Oncol. 1997;15:994-9.
38. Abu-Rustum NR, Barakat RR, Siegel PL, Venkatraman E, Curtin JP, Hoskins WJ. Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy? Obstet Gynecol. 1996;88:549-53.
39. DiSaia PJ, Creasman WT. Epithelial ovarian cancer. In: Creasman WT, ed. Clinical gynecological oncology. St. Louis: Mosby-Year Book; 1993.
40. Major AL, Rose GS, Chapman CF, Hiserodt JC, Tromberg BJ, Krasieva TB, Tadir Y, Haller U, Di-Saia PJ, Berns MW. In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol. 1997;66:122-32.
41. Hornung R, Major AL, McHale M, Liaw LHL, Sabiniano LA, Tromberg BJ, Berns MW, Tadir Y. In vivo detection of metastatic ovarian cancer by means of 5- aminolevulinic acid-induced fluorescence in a rat model. J Am Assoc Gynecol Laparosc. 1998;5:141-8.
42. Hornung R, Hammer-Wilson MJ, Kimel S, Liaw LH, Tadir Y, Berns MW. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5- aminolevulinic acid uptake kinetics by transplantable tumors. J Photochem Photobiol B. 1999;49:41-9.
43. Gahlen J, Stern J, Laubach HH, Pietschmann M, Herfarth C. Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis. Surgery. 1999;126:469-73.
44. Gahlen J, Prosst RL, Pietschmann M, Rheinwald M, Haase T, Herfarth C. Spectrometry supports fluorescence staging laparoscopy after intraperitoneal aminolaevulinic acid lavage for gastrointestinal tumours. J Photochem Photobiol B. 1999;52:131-5.
45. Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, Hammer-Wilson MJ, Liaw LH, Osann K, DiSaia PJ, Berns M, Tromberg B, Tadir Y. Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model. Gynecol Oncol. 2002;87:64-70.
46. Löning M, Diddens H, Kupker W, Diedrich K, Huttmann G. Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer. 2004;100:1650-6.
47. Löning MC, Diddens HC, Holl-Ulrich K, Löning U, Kupker W, Diedrich K, Huttmann G. Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: fluorescence microscopy studies. Lasers Surg Med. 2006;38:549-54.
48. Hillemanns P, Reiff J, Stepp H, Soergel P. Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report. Lasers Med Sci. 2007;22(3):131-5.
49. Chapman JA, Tadir Y, Tromberg BJ, Yu K, Manetta A, Sun CH, Berns MW. Effect of administration route and estrogen manipulation on endometrial uptake of Photofrin porfimer sodium. Am J Obstet Gynecol. 1993;168:685-92.
50. Bhatta N, Anderson RR, Flotte T, Schiff I, Hasan T, Nishioka NS. Endometrial ablation by means of photodynamic therapy with photofrin II. Am J Obstet Gynecol. 1992;167:1856-63.
51. Fehr MK, Tromberg BJ, Svaasand LO, Ngo P, Berns MW, Tadir Y. Structural and functional effects of endometrial photodynamic therapy in a rat model. Am J Obstet Gynecol. 1996;175:115-21.
52. Fortin M, Lepine M, Page M, Osteen K, Massie B, Hugo P, Steff AM. An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. Fertil Steril. 2003;80 Suppl 2:832-8.
53. Malik E, Meyhofer-Malik A, Berg C, Bohm W, Kunzi-Rapp K, Diedrich K, Ruck A. Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-aminolaevulinic acid. Hum Reprod. 2000;15:584-8.
54. Rocklin GB, Kelly HG, Anderson SC, Edwards LE, Gimpelson RJ, Perez RE. Photodynamic therapy of rat endometrium sensitized with tin ethyl etiopurpurin. J Am Assoc Gynecol Laparosc. 1996;3:561-70.
55. Roy BN, Van Vugt DA, Weagle GE, Pottier RH, Reid RL. Effect of 5-aminolevulinic acid dose and estrogen on protoporphyrin IX concentrations in the rat uterus. J Soc Gynecol Investig. 1997;4:40-6.
56. Steiner RA, Tromberg BJ, Wyss P, Krasieva T, Chandanani N, McCullough J, Berns MW, Tadir Y. Rat reproductive performance following photodynamic therapy with topically administered Photofrin. Hum Reprod. 1995;10:227-33.
57. Steiner RA, Tadir Y, Tromberg BJ, Krasieva T, Ghazains AT, Wyss P, Berns MW. Photosensitization of the rat endometrium following 5-aminolevulinic acid induced photodynamic therapy. Lasers Surg Med. 1996;18:301-8.
58. Van Vugt DA, Krzemien A, Roy BN, Fletcher WA, Foster W, Lundahl S, Marcus SL, Reid RL. Photodynamic endometrial ablation in the nonhuman primate. J Soc Gynecol Investig. 2000;7:125-30.
59. Wyss P, Tadir Y, Tromberg BJ, Liaw L, Krasieva T, Berns MW. Benzoporphyrin derivative: a potent photosensitizer for photodynamic destruction of rabbit endometrium. Obstet Gynecol. 1994;84:409-14.
60. Wyss P, Tromberg BJ, Wyss MT, Krasieva T, Schell M, Berns MW, Tadir Y. Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits. Am J Obstet Gynecol. 1994;171:1176-83.
61. Wyss P, Svaasand LO, Tadir Y, Haller U, Berns MW, Wyss MT, Tromberg BJ. Photomedicine of the endometrium: experimental concepts. Hum Reprod. 1995;10:221-6.
62. Wyss P, Steiner R, Liaw LH, Wyss MT, Ghazarians A, Berns MW, Tromberg BJ, Tadir Y. Regeneration processes in rabbit endometrium: a photodynamic therapy model. Hum Reprod. 1996;11:1992-7.
63. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol. 1993;57:803-7.
64. Yang JZ, Van Vugt DA, Roy BN, Kennedy JC, Foster WG, Reid RL. Intrauterine 5-aminolevulinic acid induces selective endometrial fluorescence in the rhesus and cynomolgus monkey. J Soc Gynecol Investig. 1996;3:152-7.
65. Malik E, Berg C, Meyhofer-Malik A, Buchweitz O, Moubayed P, Diedrich K. Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. Surg Endosc. 2000;14:452-5.
66. Hillemanns P, Weingandt H, Stepp H, Baumgartner R, Xiang W, Korell M. Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. Am J Obstet Gynecol. 2000;183:52-7.
67. Buchweitz O, Wulfing P, Staebler A, Kiesel L. Detection of nonpigmented endometriotic lesions with 5-aminolevulinic acid-induced fluorescence. J Am Assoc Gynec Laparosc. 2004;11:505-10.
68. Daniell JF, Kurtz BR, Ke RW. Hysteroscopic endometrial ablation using the rollerball electrode [see comments]. Obstet Gynecol. 1992;80:329-32.
69. DeCherney A, Polan ML. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet Gynecol. 1983;61:392-7.
70. Serden SP, Brooks PG. Treatment of abnormal uterine bleeding with the gynecologic resectoscope. J Reprod Med. 1991;36:697-9.
71. Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol. 1981;140:14-9.
72. Gurtcheff S, Sharp H. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol. 2003;102:1278-82.
73. Badia CD, Nyirjesy P, Atogho A. Endometrial ablation devices: review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol. 2007;14:436-41.
74. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: prevention of implantation. Am J Obstet Gynecol. 1993;168:995-1001.
75. Wyss P, Fehr M, Van den Bergh H, Haller U. Feasibility of photodynamic endometrial ablation without anesthesia. Int J Gynaecol Obstet. 1998;60:287-8.
76. Mhawech P, Renaud A, Sene C, Ludicke F, Herrmann F, Szalay-Quinodoz I, van den Bergh H, Major AL. High efficacy of photodynamic therapy on rat endometrium after systemic administration of benzoporphyrin derivative monoacid ring A. Hum Reprod. 2003;18:1707-11.
77. Tadir Y, Hornung R, Pham TH, Tromberg BJ. Intrauterine light probe for photodynamic ablation therapy. Obstet Gynecol. 1999;93:299-303.
78. Dwyer PJ, White WM, Fabian RL, Anderson RR. Optical integrating balloon device for photodynamic therapy. Lasers Surg Med. 2000;26:58-66.
79. Hornung R, Fehr MK, Tromberg BJ, Major A, Krasieva TB, Berns MW, Tadir Y. Uptake of the photosensitizer benzoporphyrin derivative in human endometrium after topical application in vivo. J Am Assoc Gynecol Laparosc. 1998;5:367-74.
80. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg. 1996;14:289-304.
81. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, Shulman DG. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. J Clin Laser Med Surg. 1996;14:59-66.
82. Degen AF, Gabrecht T, Mosimann L, Fehr MK, Hornung R, Schwarz VA, Tadir Y, Steiner RA, Wagnieres G, Wyss P. Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers Surg Med. 2004;34:1-4.
83. Wyss P, Caduff R, Tadir Y, Degen A, Wagnieres G, Schwarz V, Haller U, Fehr M. Photodynamic endometrial ablation: morphological study. Lasers Surg Med. 2003;32:305-9.
84. Koren H, Alth G. Photodynamic therapy in gynaecologic cancer. J Photochem Photobiol B. 1996;36:189-91.
85. Cuenca R, Allison R, Sibata C, Downie G. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11:322-7.
86. Wyss P, Schwarz V, Dobler-Girdziunaite D, Hornung R, Walt H, Degen A, Fehr M. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. Int J Cancer. 2001;93:720-4.
87. Allison R, Mang T, Hewson G, Snider W, Dougherty D. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer. 2001;91:1-8.
88. Taber S, Fingar V, Wieman T. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol. 1998;68(4):209-14.
89. Khan S, Dougherty T, Mang T. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer. 1993;29A:1686-90.
90. Schuh M, Nseyo U, Potter W, Dao T, Dougherty T. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol. 1987;5(11):1766-70.